HJ Science Co., Ltd. (SEHK: 6132)
Health Care · Biotechnology · CN
HK$41.46
+1.52% today · +17.6% 1Y
HJ Science Co., Ltd. (SEHK: 6132) operates in the Biotechnology industry within the Health Care sector. The company is valued at $388.85M and employs 115 people.
Over the last twelve months the share price has gained 17.6%, trading between 30.78 and 82.00.
6132 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $388.85M
- Revenue (TTM)
- $1.87M
- P/E
- —
- EPS
- -2.28
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$82.00
- 52-week low
- HK$30.78
- Avg volume (3M)
- —
- Shares outstanding
- 73.60M
- Employees
- 115
- Next earnings
- —
About HJ Science Co., Ltd.
HJ Science Co., Ltd. is a clinical stage biotech company, which engages in research and development of small molecule drugs for tumors, autoimmune & metabolic system diseases for clinical treatments. It provides drug design, in vivo and in vitro activity evaluation, drug metabolism, synthesis, quality research, formulation development, and scale-up. Its products include HJ787, HJ178 and HJ891. The company was founded by Ji Jianxin on February 20, 2017 and is headquartered in Chengdu, China.
- ISIN
- CNE100007PD2
- Founded
- 2017
- Listed since
- Jun 23, 2026
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $464.58B | $262.90 | -1.09% |
| Amgen Inc.NasdaqGS: AMGN | $238.06B | $440.34 | -0.43% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $183.64B | $148.09 | -0.01% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.72B | $547.29 | -1.01% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $81.36B | $814.79 | -2.25% |
| argenx SEENXTBR: ARGX | $65.40B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $59.75B | $149.66 | -5.77% |
| CSL LimitedASX: CSL | $59.19B | AU$172.44 | -0.69% |
Figures last refreshed Aug 18, 2026.